1. McGann PT; Hernandez AG; Ware RE. Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood. 2017; 129:155-161.
  2. Shaw MA; Kombrinck KW; McElhinney KE; Sweet DR; Flick MJ; Palumbo JS; Cheng M; Esmon NL; Esmon CT; Brill A. Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice. Blood. 2016; 128:721-731.
  3. Bakeer N; James J; Roy S; Wansapura J; Shanmukhappa SK; Lorenz JN; Osinska H; Backer K; Huby AC; Shrestha A. Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113:E5182-E5191.
  4. Key NS; Khorana AA; Mackman N; McCarty OJT; White GC; Francis CW; McCrae KR; Palumbo JS; Raskob GE; Chan AT. Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group. Cancer Research. 2016; 76:3671-3675.
  5. Goyama S; Shrestha M; Schibler J; Rosenfeldt L; Miller W; O'Brien E; Mizukawa B; Kitamura T; Palumbo JS; Mulloy JC. Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia. Oncogene: Including Oncogene Reviews. 2017; 36:2589-2598.
  6. Marahatta A; Megaraj V; McGann PT; Ware RE; Setchell KDR. Stable-Isotope Dilution HPLC-Electrospray Ionization Tandem Mass Spectrometry Method for Quantifying Hydroxyurea in Dried Blood Samples. Clinical chemistry. 2016; 62:1593-1601.
  7. Shaw MA; Gao Z; McElhinney KE; Thornton S; Flick MJ; Lane A; Degen JL; Ryu JK; Akassoglou K; Mullins ES. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2017; 37:3776-3788.
  8. Pecker LH; Schaefer BA; Luchtman-Jones L. Knowledge insufficient: the management of haemoglobin SC disease. British Journal of Haematology. 2017; 176:515-526.
  9. Dowling MM; Quinn CT; Ramaciotti C; Kanter J; Osunkwo I; Inusa B; Iyer R; Kwiatkowski JL; Johnson C; Rhodes M. Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke. British Journal of Haematology. 2017; 176:300-308.
  10. Chonat S; Chandrakasan S; Kalinyak KA; Ingala D; Gruppo R; Kalfa TA. Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab. British Journal of Haematology. 2016; 175:744-747.
  11. Quinn CT; Paniagua MC; DiNello RK; Panchal A; Geisberg M. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies. British Journal of Haematology. 2016; 175:724-732.
  12. Nottage KA; Ware RE; Aygun B; Smeltzer M; Kang G; Moen J; Wang WC; Hankins JS; Helton KJ. Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia. British Journal of Haematology. 2016; 175:331-338.
  13. Giangrande P; Andreeva T; Chowdary P; Ehrenforth S; Hanabusa H; Leebeek FWG; Lentz SR; Nemes L; Poulsen LH; Santagostino E. Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A. Thrombosis and haemostasis. 2017; 117:252-261.
  14. Quinn CT; Smith EP; Arbabi S; Khera PK; Lindsell CJ; Niss O; Joiner CH; Franco RS; Cohen RM. Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia. American Journal of Hematology. 2016; 91:1195-1201.
  15. Cronin RM; Hankins JS; Adams-Graves P; Thompson AA; Kalinyak K; Byrd J; McClain B; Kassim A; DeBaun M; Treadwell M. Barriers and facilitators to research participation among adults, and parents of children with sickle cell disease: A trans-regional survey. American Journal of Hematology. 2016; 91:E461-E462.
  16. Crosby LE; Joffe NE; Davis B; Quinn CT; Shook L; Morgan D; Simmons K; Kalinyak KA. Implementation of a Process for Initial Transcranial Doppler Ultrasonography in Children With Sickle Cell Anemia. American Journal of Preventive Medicine. 2016; 51:S10-S16.
  17. Cohen RM; Smith EP; Arbabi S; Quinn CT; Franco RS. Do Red Blood Cell Indices Explain Racial Differences in the Relationship between Hemoglobin A1c and Blood Glucose?. The Journal of Pediatrics. 2016; 176:7-9.
  18. Crosby LE; Joffe NE; Peugh J; Ware RE; Britto MT. Pilot of the Chronic Disease Self-Management Program for Adolescents and Young Adults With Sickle Cell Disease. Journal of Adolescent Health. 2017; 60:120-123.
  19. Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematology-American Society of Hematology Education Program. 2016; 2016:690-697.
  20. Schaefer BA; Flanagan JM; Alvarez OA; Nelson SC; Aygun B; Nottage KA; George A; Roberts CW; Piccone CM; Howard TA. Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia. PloS one. 2016; 11:e0164364.
  21. Mineo C; Lanier L; Jung E; Sengupta S; Ulrich V; Sacharidou A; Tarango C; Osunbunmi O; Shen YM; Salmon JE. Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis. PloS one. 2016; 11:e0158757.
  22. Niss O; Chonat S; Dagaonkar N; Almansoori MO; Kerr K; Rogers ZR; McGann PT; Quarmyne MO; Risinger M; Zhang K. Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells, Molecules, and Diseases. 2016; 61:4-9.
  23. Mullins ES; Stasyshyn O; Alvarez-Román MT; Osman D; Liesner R; Engl W; Sharkhawy M; Abbuehl BE. Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A. Haemophilia. 2017; 23:238-246.
  24. Lim MY; Cheng D; Aschman D; Dunn A; Ahuja S; Carpenter SL; Davis JA; French J; Gruppo R; Knoll C. Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset. Haemophilia. 2017; 23:e160-e162.
  25. Brand B; Gruppo R; Wynn TT; Griskevicius L; Lopez Fernandez MF; Chapman M; Dvorak T; Pavlova BG; Abbuehl BE. Efficacy and safety of pegylated full- length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients. Haemophilia. 2016; 22:e251-e258.